Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENTECAVIR vs EPCORITAMAB-BYSP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENTECAVIR vs EPCORITAMAB-BYSP: Safety Overview

Metric ENTECAVIR EPCORITAMAB-BYSP
Total FAERS Reports 4,487 978
Deaths Reported 726 341
Death Rate 16.2% 34.9%
Hospitalizations 1,133 199
Average Patient Age 55.0 yrs 71.6 yrs
% Female Patients 38.1% 41.6%
FDA Approval Date Aug 10, 2020 N/A
Manufacturer Zydus Lifesciences Limited N/A
Route ORAL N/A
Marketing Status Prescription Prescription